CV Sciences, operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division in manufacturing, marketing and selling plant-based Injection of Innovative Tech into Booming Cannabis Industry Creating Lucrative Revenue Streams for Marijuana Stocks

thumbnail courtesy of kswo.com